Profession Notes

To improve the application of basic research to clinical treatment, the National Institute of Mental Health has established a $2.75 million translational research program. The program evolved in response to NIMH concerns that findings in basic research were not being put into practice, explains Bruce Cuthbert, chief of the Adult Psychopathology and Prevention Research Program at NIMH. An example of such translational research, Cuthbert says, would be to apply basic findings in motivational psych

Written byHarvey Black
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
To improve the application of basic research to clinical treatment, the National Institute of Mental Health has established a $2.75 million translational research program. The program evolved in response to NIMH concerns that findings in basic research were not being put into practice, explains Bruce Cuthbert, chief of the Adult Psychopathology and Prevention Research Program at NIMH. An example of such translational research, Cuthbert says, would be to apply basic findings in motivational psychology to the treatment of bipolar disorders. The program could, for example, fund a network of three to 12 scientists who work with clinicicians to translate findings into treatments. The translational grants could also provide funds to establish large-scale centers that blend research and clinical work or support the work of a single investigator. Program officials are reviewing 30 grant applications, but have not yet named award recipients. A second request for applications will be made before year's end.
--Harvey Black

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies